Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 31 clinical trials
featured
An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

  • 780 views
  • 25 Mar, 2021
  • 30 locations
A Study to Assess the Safety Tolerability and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly

The purpose of this study is to determine the safety, tolerability, and efficacy of IONIS-GHR-LRx subcutaneous (SC) injection as monotherapy in patients with acromegaly.

pasireotide
bromocriptine
gh receptor
insulin-like growth factor
igf1
  • 0 views
  • 11 Jul, 2021
  • 19 locations
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

The purpose of this trial is to assess the efficacy and safety of CAM2029 in patients with acromegaly. Patients will be randomized to either CAM2029 or placebo administered subcutaneously once

octreotide
lanreotide
hepatic disease
insulin-like growth factor
somatomedin c
  • 15 views
  • 03 Jul, 2021
  • 50 locations
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

The purpose of this trial is to assess the long-term safety of CAM2029 in patients with acromegaly. Patients will be administered CAM2029 subcutaneously once monthly during 12 months. Patients

octreotide
lanreotide
hepatic disease
insulin-like growth factor
somatomedin c
  • 60 views
  • 08 Sep, 2021
  • 51 locations
Acromegaly Combination Treatment Study

at a lower cost, compared to combination high dose SRL and weekly Pegvisomant. Lower doses of therapy will greatly reduce cost of acromegaly therapy.

lfts
hepatic disease
dopamine agonists
insulin-like growth factor
somatostatin
  • 114 views
  • 25 Jan, 2021
  • 1 location
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly

) in subjects with acromegaly previously treated with somatostatin receptor ligand (SRL) based treatment regimens.

somatostatin
insulin-like growth factor
igf1
  • 0 views
  • 13 Aug, 2021
  • 4 locations
Estrogen Treatment in Acromegalic Women

Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs.

somatostatin
  • 29 views
  • 07 Nov, 2020
  • 1 location
Effects of Mindfulness Therapy in Patients With Acromegaly and Cushing

mindfulness and compassion, lasting 120 minutes, weekly, which will take place over 8 weeks. Two separate studies will be done, one for patients with acromegaly which will be the first to take place

  • 0 views
  • 26 Jan, 2021
  • 1 location
Modulating the GIP System in Patients With Acromegaly Due to a Pituitary Tumor

Modulation of the GIP System in Patients With Acromegaly Due to a Pituitary adenoma

  • 1 views
  • 16 Aug, 2021
  • 2 locations
Very Large Sizes in Adolescents : Tibial and Femoral EPIphysiodesis

The very large sizes can be very disabling and at the origin of a difficult psychological experience. Some families are in demand for a growth-curbing treatment. Currently, only hormonal treatments are offered in France but they are at the origin of many side effects. Northern European countries applied a surgical …

  • 0 views
  • 17 Mar, 2021
  • 5 locations